Neuros Medical Announces Successful Pilot Study: Data to be presented at International Neuromodulation Society’s World Congress
Cleveland, OH (June 4, 2013) – Neuros Medical, Inc., a medical device company announced significant results today from their long term pilot study. The study evaluated the Company’s patented on-demand, high frequency Electrical Nerve Block technology which focused on patients afflicted with chronic amputation pain. This debilitating condition affects nearly one million patients in the U.S. alone. (more…)
Tryton Medical Announces Successful Live Case Transmission With New Tryton Side Branch SHORT Stent
Data and Presentations at EuroPCR Highlight Consistently Positive Clinical Results
Durham, N.C. – May 29, 2013 – Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case (more…)
Tryton Medical Announces Nordic-Baltic Dedicated Bifurcation Trial Studying the Tryton Side Branch Stent
PARIS – May 23, 2013 – Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton Side Branch Stent. (more…)
Tryton Medical Announces CE Mark and European Launch of Next-Generation Tryton Side Branch SHORT Stent
New Stent Will Be Featured at EuroPCR 2013 Exhibit Booth #M27 May 21-24 in Paris
Durham, N.C. – May 16, 2013 – Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the company received the CE Mark for the Tryton Side Branch SHORT Stent, a novel coronary stent system that broadens the treatment options in bifurcations in large vessels with a short main branch landing zone. (more…)
Lumena Pharmaceuticals Announces $23 Million Series A Financing
Funding to support clinical development of drug candidates to treat rare liver diseases
SAN DIEGO – May 8, 2013 – Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the company has secured $23 million in Series A financing. Investors include Pappas Ventures, RiverVest Venture Partners and Alta Partners. (more…)
St. Mary Medical Center and Centerre Healthcare Partner in Opening New Inpatient Rehabilitation Specialty Hospital
State-of-the-art facility to be first free-standing rehabilitation hospital in Bucks County
LANGHORNE, PA, April 29, 2013 – St. Mary Medical Center in Langhorne, PA, in partnership with Centerre Healthcare Corporation, headquartered in Nashville, TN, today announced plans for a newly designed acute rehabilitation hospital, the first specialty hospital of its kind in Bucks County. (more…)
Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
New claim will help physicians better guide treatment with P2Y12 Inhibitors
April 16, 2013, San Diego, CA – Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to assess whether a patient may be at greater risk for both bleeding or ischemic events, as an aid to manage therapeutic treatment decisions and accurately assess the antiplatelet effect from P2Y12 inhibitors (such as clopidogrel, prasugrel and ticagrelor). (more…)
Mercy Breaks Ground on New Rehabilitation Hospital
Springfield, MO. (April 2, 2013) — Rehabilitation services in the Ozarks will get a major upgrade, as crews begin work on the new Mercy Rehabilitation Hospital Springfield.
The $28 million, 63,000 square foot facility will have 60 beds and provide inpatient rehabilitation for patients who are recovering from strokes, brain or spinal cord injuries, amputations, complex orthopedic injuries and other conditions. Construction is estimated to take about a year. (more…)
Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
New Studies Demonstrate Cost Effectiveness, Clinical Value in a Stent Population and Validation of a Therapeutic Window using the VerifyNow System
March 12, 2013, San Diego, CA – Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced the presentation of a series of important data that solidifies the clinical utility of platelet reactivity testing. Real world outcomes data in high risk patients receiving stents, a cost effectiveness analysis, and validation of a therapeutic window continue to demonstrate platelet reactivity as a critical element for improving the quality of care for the millions of patients on antiplatelet therapies worldwide. (more…)
University Hospitals and Centerre Healthcare ready for first patients Comprehensive Inpatient Rehabilitation Hospital
Construction complete, new patients scheduled for end of March
CLEVELAND – Feb. 27, 2013 - University Hospitals (UH) and Nashville-based Centerre Healthcare Corporation announced today that construction is near completion on their joint venture, UH Rehabilitation Hospital, a comprehensive inpatient rehabilitation hospital in Beachwood, OH. (more…)